Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

🩺 Protocol Summary

The purpose of this study is to investigate possible genetic factors that contribute to the development of lymphomas. The databank will be used to determine whether familial lymphomas have unique genetic characteristics different from sporadic lymphomas and to attempt to identify a gene that confers an increased risk of lymphoma.

Primary Research Facility: Dana-Farber Cancer Institute (Boston, Massachusetts)

Answer all 3 basic criteria below to see your preliminary screening result:

📍 Primary Site Map

Site: Dana-Farber Cancer Institute — Boston, Massachusetts

💰 Clinical Trial Costs & Insurance Coverage

Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act § 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.

💡 Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.